AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 2.73.
Share Price | ₹1,394.7 | Nov 06,2024 |
Market Cap | ₹81,001.3 Cr | |
Sales-TTM | ₹29,718.4 Cr | TTM-Consolidated Results |
Price/Sales | 2.73x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹81,001.3 Cr] as on Nov 06,2024
(/) Sales [ ₹29,718.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.73x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.64x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 1.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2024 at 2.2x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2020 of 1.05x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
AUROBINDO PHARMA | 29,718.4 | 2.73 | 81,001.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.71 | 438,418.0 |
CIPLA LTD | 26,512.0 | 4.86 | 128,755.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.61 | 108,720.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 4.86 | 100,120.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 19.26 | 157,680.0 |
MANKIND PHARMA LTD | 11,018.0 | 10.00 | 110,181.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.68 | 108,624.0 |
LUPIN LTD | 20,797.1 | 4.75 | 98,759.4 |
ABBOTT INDIA LTD | 5,927.5 | 10.44 | 61,867.8 |
ALKEM LABORATORIES LTD | 12,731.7 | 5.50 | 69,979.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.73x |
Max industry PS | 19.26x |
Median industry PS | 5.50x |
Average industry PS | 7.67x |
You may also like the below Video Courses